Strata Critical Medical, Inc.
NASDAQ Global MarketTotal Valuation
Strata Critical Medical, Inc. carries a market capitalization of 42,455.00, placing it among publicly traded companies globally. Its enterprise value stands at -54.32M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 42,455.00 |
| Enterprise Value | -54.32M |
Share Statistics
Strata Critical Medical, Inc. currently has 86.52M shares outstanding.
| Shares Outstanding | 86.52M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Strata Critical Medical, Inc. maintains a current ratio of 5.93, meaning it holds 5.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 5.93 |
| Quick Ratio | 4.70 |
| Debt / Equity | 1.56 |
| Debt / EBITDA | -0.43 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 16.26 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | 21,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Strata Critical Medical, Inc.'s stock has declined approximately -99.74249% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.12.
| Beta (5Y) | N/A |
| 52-Week Price Change | -99.74249% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.12 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -10.41M, while operating income came in at -19.95M.
| Revenue | 254.27M |
| Gross Profit | 55.14M |
| Operating Income | -19.95M |
| Pretax Income | -16.36M |
| Net Income | 46.99M |
| EBITDA | -10.41M |
| EBIT | -19.95M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Strata Critical Medical, Inc. holds 58.79M in cash and equivalents against 4.47M in total debt, resulting in a net debt position of -58.72M. Total book value stands at -143.39M, with working capital of 103.20M providing operational flexibility.
| Cash & Cash Equivalents | 58.79M |
| Total Debt | 4.47M |
| Net Debt | -58.72M |
| Equity (Book Value) | -143.39M |
| Book Value Per Share | N/A |
| Working Capital | 103.20M |
Cash Flow
Strata Critical Medical, Inc. produced -44.78M in operating cash flow over the past twelve months.
| Operating Cash Flow | -44.78M |
| Capital Expenditures | -12.16M |
| Free Cash Flow | -56.94M |
| FCF Per Share | N/A |
Margins
Strata Critical Medical, Inc. operates with a gross margin of 21.68, reflecting its pricing power and cost economics. The operating margin of -7.85 and net profit margin of 18.48 provide insight into operational efficiency.
| Gross Margin | 21.68 |
| Operating Margin | -7.85 |
| Pretax Margin | -6.44 |
| Profit Margin | 18.48 |
| EBITDA Margin | -4.09 |
Scores
Strata Critical Medical, Inc. posts an Altman Z-Score of 0.58, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.58 |